Evidence map›Paper›PMID 35754872›Full record

ArticleRSC advances2022

Metal- and base-free tandem sulfonylation/cyclization of 1,5-dienes with aryldiazonium salts

Xiaohong Wang, Fengzhi You, Baojian Xiong, Lei Chen, Xuemei Zhang, Zhong Lian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaohong WangDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.
Fengzhi YouDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.
Baojian XiongDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.
Lei ChenDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.
Xuemei ZhangDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.
Zhong LianDepartment of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, West China School of Pharmacy, Sichuan University Chengdu 610041 China xuemeizhang@scu.edu.cn lianzhong@scu.edu.cn.ORCID https://orcid.org/0000-0003-2533-3066

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A metal- and base-free 5-

Identifiers

PMID35754872
PMCPMC9170380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.